Results 241 to 250 of about 298,517 (337)

fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study. [PDF]

Allergy Asthma Clin Immunol
Čižnár P, Roderick M, Schneiderova H, Jeseňák M, Kriván G, Brodszki N, Jolles S, Atisso C, Fielhauer K, Saeed-Khawaja S, McCoy B, Yel L.   +11 more
europepmc   +1 more source

A Critical View of Specific Antibody Deficiencies

Frontiers in Immunology, 2019
Ricardo U. Sorensen, Ricardo U. Sorensen, Ricardo U. Sorensen   +2 more
doaj   +1 more source

Virological and Immunological Effects of Combination Antiretroviral Therapy with Zidovudine, Lamivudine, and Indinavir during Primary Human Immunodeficiency Virus Type 1 Infection [PDF]

, 2000
Don Smith, M. Michelle Berrey, Michael Robertson, Devan V. Mehrotra, Martin Markowitz, Luc Perrin, Nathan Clumeck, Adriano Lazzarin, Beat Burckhardt, Rainer Weber, Lawrence Corey, David A. Cooper   +11 more
openalex   +1 more source

Synthesis of Rhamnose‐Modified Lewis‐X‐Containing Saponins

European Journal of Organic Chemistry, Accepted Article.
We report the synthesis of betulinic acid and echinocystic acid saponins featuring an unnatural analogue of the Lewis‐X trisaccharide, in which the l‐fucose residue is replaced by l‐rhamnose. These triterpenoid saponins were designed as negative controls for dendritic cell‐specific intercellular adhesion molecule‐3‐grabbing non‐integrin (DC‐SIGN ...
Oscar Javier Gamboa Marin, Nitish Verma, Maude Cloutier, Charles Gauthier   +3 more
wiley   +1 more source

A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents. [PDF]

Immunotherapy
Fasshauer M, Schuermann G, Gebert N, Bernuth HV, Bullinger M, Goldacker S, Krueger R, Manzey P, Messner S, Renner ED, Ritterbusch H, Schauer U, Schulze I, Umlauf V, Widmann S, Baumann U.   +15 more
europepmc   +1 more source

Corrigendum to “Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs)”

Journal of the Formosan Medical Association, 2012
Wen-I. Lee, Jing-Long Huang, Kuo-Wei Yeh, Tang-Her Jaing, Tzou-Yien Lin, Yhu-Chering Huang, Cheng-Hsun Chiu   +6 more
doaj   +1 more source

Neutralization of primary and T-cell line adapted isolates of human immunodeficiency virus type 1: role of V3-specific antibodies.

, 1998
Simon Beddows, Peter Simmonds, Philippa Easterbrook, S Louisirirotchanakul, Jonathan Weber, R. Cheingsong‐Popov   +5 more
openalex   +1 more source

The RNA Binding Protein Bcas2 is Required for Antibody Class Switch in Activated‐B Cells

Exploration, EarlyView.
Bcas2 recruits DHX15 and SRSF7 to form a protein complex for the splicing of CSR‐related mRNA at the 5' ss and 3' ss, generating two mature mRNA isoforms, which are ultimately translated into CSR‐related proteins. These CSR‐related proteins bind to DNA associated with antibodies, affecting the DSB repair of the relevant DNA after AID induction, thereby
Yu Chen, Siyuan Sun, Chenxu Lu, Yixuan Li, Bing Fang, Xiangfeng Tang, Xuepeng Li, Weiru Yu, Yumei Lei, Longjie Sun, Ming Zhang, Jiazeng Sun, Ping Liu, Yongting Luo, Xingwang Zhao, Jing Zhan, Libing Liu, Rong Liu, Jiaqiang Huang, Ziwei Yi, Yifei Yu, Weihan Xiao, Zheng Ding, Lei Li, Dan Su, Fazheng Ren, Changchang Cao, Ran Wang, Wenbiao Shi, Juan Chen   +29 more
wiley   +1 more source

Lymphoproliferation, Autoimmunity, and Recurrent Infections: Which Primary Immunodeficiency? [PDF]

Turk Arch Pediatr
Öztürk G, Haskoloğlu Ş, Deveci N, Erkmen H, Çelik NA, Sucak G, Ceylaner S, İkincioğulları A, Doğu F.   +8 more
europepmc   +1 more source

Primary induction of human cytotoxic lymphocytes against a synthetic peptide of the human immunodeficiency virus type 1 protease.

, 1997
J. K�nya, Eva Maria Feny�, Joakim Dillner, György Stuber, A Bj√∂rndal   +4 more
openalex   +1 more source